Fermer le menu


Member of Lyonbiopole


Skyepharma is a French independent CDMO, specialized in the formulation and manufacturing of oral solid dosage forms (small molecules), with a core expertise on complex drugs (modified release, controlled substances, HPAPI, rare diseases).

Skyepharma also offers through its innovative Skyehub concept, tailor-made capacity for clinical and commercial bioproduction.


Strategic application domain: Human Medicine

Application market: Bioproduction, Oncology, Rare disease

Type of activity: CMO - Production - Bioproduction

Technologies: Drug delivery device & Technologies, Small Molecules, Others

Created on oct. 1st, 1996 - 170 employees



55 rue du montmurier 38070 Saint-Quentin-Fallavier



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.